Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study

Table 2

Correlation of GRP78 with various clinicopathological factors for early-stage lung cancer patients.

Parameters	Mean (pg/mL) ± SE	p value
Age (years)
≤60	232.9 ± 54.22	0.0534
>60	424.8 ± 82.58
Gender
Male	313.3 ± 61.08	0.7350
Female	348.3 ± 86.23
pT
T1-T2	118.91 ± 426.24	0.2483
T3	300.52 ± 441.76
Stage
I-II	295.3 ± 59.96	0.4600
III	370.6 ± 85.65
Differentiation
Well and moderate	363.2 ± 81.65	0.4755
Poor	291.6 ± 58.77

SE: standard error, pT: pathological tumor.